Novedades

• US generics launch and approval for Dr Reddy’s and Lupin
• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs
• Revlimid (lenalidomide) generics launch across Europe

Investigación

• Evaluation of pharmaceutical equivalency of manufactured generic drugs in UAE
• New insights into the amount of R & D for new uses of generic drugs
• Pricing and reimbursement of medicines in Canada
• Medicines pricing conditions in Italy and Brazil: comparison of regulations

General

• FDA releases one-year progress report for the Generic Drug Cluster
• Empresas de fabricación de productos farmacéuticos en Brasil
• Empresas farmacéuticas en Argentina
• Empresas farmacéuticas en América Latina y el Caribe

Novedades

• Biosimilar launches in Canada and US: Byooviz and Stimufend
• EMA recommends approval of eculizumab biosimilar Bekemv
• China approves tocilizumab copy biological BAT1806
• FDA accepts application for denosumab biosimilar GP2411

Investigación

• Low biosimilar uptake in regions of low social and political trust
• A global overview of manufacturers of follow-on biologicals
• Study supports increased development of insulin biosimilars
• Perspectiva y papel de los farmacéuticos hospitalarios de Malasia en la promoción del uso de biosimilares

General

• Retos de la industria española de genéricos y biosimilares: rentabilidad sostenible
• Lilly, Novo Nordisk and Sanofi slash prices of insulin in the US
• American College of Rheumatology position statement on biosimilars updated
• Biosimilars approved in Canada

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados